Can stopping Zoloft (sertraline) cause dizziness and nausea in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antidepressant Discontinuation Syndrome with Sertraline (Zoloft)

Yes, stopping Zoloft (sertraline) can absolutely cause dizziness and nausea—these are well-documented withdrawal symptoms that occur when the medication is discontinued, particularly if stopped abruptly. 1

Evidence for Dizziness and Nausea as Withdrawal Symptoms

The FDA drug label for sertraline explicitly warns that stopping the medication too quickly may cause serious symptoms including dizziness and nausea, along with headache, sweating, electric shock-like sensations, shaking, and confusion. 1

High-quality evidence from randomized placebo-controlled trials (6,729 participants) demonstrates that patients discontinuing antidepressants experience significantly more withdrawal symptoms compared to placebo groups, specifically:

  • Dizziness (documented in seven studies) 2
  • Nausea (documented in six studies) 2
  • Vertigo (documented in one study) 2

Clinical Characteristics of Sertraline Withdrawal

Timing and Duration

  • Symptoms typically begin within 24-48 hours after discontinuation 3, 4
  • Symptoms reach maximum intensity around day 5 3
  • Duration typically lasts up to 3 weeks, though most resolve within 2-3 weeks 3, 5
  • In documented cases, symptoms persisted for up to 21 days (mean 11.8 days) after onset 6

Severity Factors

Sertraline has a shorter half-life compared to fluoxetine, making withdrawal symptoms more likely. 6 In a retrospective study of 352 patients, withdrawal symptoms occurred in:

  • 17.2% of patients on shorter half-life SSRIs (including sertraline) 6
  • Only 1.5% of patients on longer half-life SSRIs like fluoxetine 6

The intensity of withdrawal symptoms depends on:

  • Daily dose (higher doses = more severe symptoms) 3
  • Duration of treatment (longer treatment = more severe symptoms; median 28 weeks in cases vs. 16 weeks in non-cases) 3, 6

Complete Symptom Profile

Beyond dizziness and nausea, patients may experience:

  • Sensory disturbances: electric shock-like sensations, paresthesias 1, 4, 5
  • Neurological: headache, lethargy, confusion 1, 6, 5
  • Gastrointestinal: vomiting, diarrhea, abdominal cramps 4
  • Psychiatric: anxiety, irritability, agitation, emotional lability, insomnia, vivid dreams 1, 6, 5
  • Flu-like symptoms: malaise, muscular pains, asthenia 3, 4

Management Algorithm

Immediate Management

  1. If symptoms are intolerable: Restart sertraline at the previous dose—symptoms resolve within 24 hours of restarting the medication 3, 6
  2. Benzodiazepines do NOT relieve these symptoms 6

Prevention Strategy

The FDA label explicitly states: "A gradual reduction in the dose rather than abrupt cessation is recommended whenever possible." 1

  • Taper the dose over several weeks rather than stopping abruptly 1, 4
  • If intolerable symptoms occur during tapering, resume the previous dose and decrease more gradually 1
  • Patient education about potential withdrawal symptoms is essential 3

Critical Clinical Caveat

Do not confuse withdrawal symptoms with serotonin syndrome. If dizziness and nausea appear as part of a constellation including mental status changes, autonomic instability (racing heartbeat, high/low blood pressure, sweating, fever), muscle rigidity, or coordination problems, this represents serotonin syndrome—a life-threatening emergency requiring immediate discontinuation of all serotonergic medications. 7, 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Paroxetine withdrawal syndrome].

Annales de medecine interne, 2000

Research

Serotonin reuptake inhibitor withdrawal.

Journal of clinical psychopharmacology, 1996

Guideline

Gastrointestinal Effects of Antidepressants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can a patient's symptoms still be attributed to withdrawal from antidepressants, such as fluoxetine (Selective Serotonin Reuptake Inhibitor) and escitalopram (Selective Serotonin Reuptake Inhibitor), as well as other medications including a mood stabilizer, anxiolytic, and stimulant, 3 months after discontinuation?
Can a patient on Cymbalta (duloxetine) 20mg and Vyvanse (lisdexamfetamine) 20mg experience withdrawal symptoms, including rebound anxiety, after missing one day of medication due to a colonoscopy, or could the symptoms be related to medications administered during the procedure?
Can combined withdrawal from Effexor (venlafaxine) and Wellbutrin (bupropion) cause vertigo?
How to discontinue Paroxetine (Selective Serotonin Reuptake Inhibitor) 10 mg?
What could be causing tingling in the lower legs of a patient with a history of anxiety, who recently discontinued SSRI (Selective Serotonin Reuptake Inhibitor) medication after 4 months, and previously experienced side effects including paresthesia (energy flowing) in the arms, urticaria (hives) on the face, and insomnia while on the medication?
What is the best management approach for a patient with atrial fibrillation (A fib) and rapid ventricular response (RVR)?
What are the management options for extra-gastric manifestations of gastroesophageal reflux disease (GERD)?
What is the immediate treatment for a patient experiencing anaphylaxis?
What treatment plan is recommended for a patient with a history of low transanal fistulotomy (involving less than 30% of the anal sphincter) to promote healing, manage discomfort, and potentially restore anal sensations and sexual well-being?
Can I switch from Rotarix (rotavirus vaccine) to Rotasil (rotavirus vaccine) for an infant who has already received the first dose of Rotarix?
What are the optimal settings for Morpheus 8 (microneedling device) treatment in patients undergoing facial rejuvenation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.